Implanon NXT®: Update to the insertion and removal instructions in the Local Product Circular to minimise the risk of intravascular insertion and neurovascular injury

MSD Pharma (Singapore) Pte. Ltd would like to inform all healthcare professionals who perform insertion or removal of Implanon NXT® on the updated insertion and removal instructions to minimise the risk of intravascular insertion and neurovascular injury. The updated sections include those related to the site of insertion and the procedures for implant insertion and removal in order to further minimize the risk of deep insertion and its potential consequences, including the rare events of intravascular insertion and neurovascular injury. Please refer to the letter for details.

 
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.moh.gov.sg/hpp/, and follow the procedures below to access the MOH Alert system.

Step 1: On the top navigation ribbon of webpage, select 'For Healthcare Professionals' followed by 'Health Professionals Portal' and click on the choice of profession. User will be redirected to the specific HPP webpage for the selected profession.

Step 2: Click on the Restricted Content icon on the left panel of webpage and login via SingPass.

Step 3: Click on the MOH Alert icon under ‘Applications’ section

Step 4: Click on the Drug Alert tab to view the DHCPLs.